According to GlaxoSmithKline's latest financial reports the company's current revenue (TTM) is $38.54 B. In 2022 the company made a revenue of $35.53 B a decrease over the years 2021 revenue that were of $40.03 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $37.84 B | 6.5% |
2022 | $35.53 B | -11.24% |
2021 | $40.03 B | -8.32% |
2020 | $43.66 B | 1.33% |
2019 | $43.09 B | 5.76% |
2018 | $40.74 B | 2.99% |
2017 | $39.56 B | 7.25% |
2016 | $36.89 B | 1.94% |
2015 | $36.19 B | -3.79% |
2014 | $37.61 B | -10.04% |
2013 | $41.81 B | -1.12% |
2012 | $42.28 B | -2.33% |
2011 | $43.29 B | -0.57% |
2010 | $43.54 B | -2.66% |
2009 | $44.73 B | 2.6% |
2008 | $43.59 B | -4.42% |
2007 | $45.61 B | 5.66% |
2006 | $43.17 B | 11.58% |
2005 | $38.69 B | 2.7% |
2004 | $37.67 B | 8.5% |
2003 | $34.72 B | 30.53% |
2002 | $26.60 B | 3.3% |
2001 | $25.75 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $49.92 B | 29.53% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 51.77% | ๐บ๐ธ USA |
Sanofi SNY | $50.51 B | 31.06% | ๐ซ๐ท France |
Merck MRK | $60.11 B | 55.96% | ๐บ๐ธ USA |
AstraZeneca AZN | $47.61 B | 23.53% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.84 B | -58.89% | ๐ฎ๐ฑ Israel |
Dynavax Technologies
DVAX | $0.23 B | -99.40% | ๐บ๐ธ USA |